Skip to main content

ENALAPRILAT

Tracking # 20-816803

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

ENALAPRILAT INJECTION IS USED IN THE MANAGEMENT OF HYPERTENSION WHEN ORAL THERAPY IS NOT PRACTICAL. ENALAPRILAT IS THE ACTIVE METABOLITE OF THE ORAL PRODRUG ENALAPRIL MALEATE. ENALAPRILAT IS POORLY ABSORBED ORALLY AND REQUIRES INTRAVENOUS ADMINISTRATION. IT INHIBITS ANGIOTENSIN I TO ANGIOTENSIN II CONVERSION VIA COMPETITIVE INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME (ACE). THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, PHARMACOLOGY, MONITORING, AND RELEVANT INTERACTIONS OF ENALAPRILAT, PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT OF PATIENTS WITH CONDITIONS WHERE THIS AGENT IS INDICATED.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I